Celexa and Micronase drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Celexa (citalopram hydrobromide) and Micronase (glyburide). Common drug interactions include dyspnoea exertional among females and atrioventricular block first degree among males.

The phase IV clinical study analyzes what interactions people have when they take Celexa and Micronase. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Celexa?

Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,390 Celexa users. Check the latest studies of Celexa.

What is Micronase?

Micronase has active ingredients of glyburide. eHealthMe is studying from 1,922 Micronase users. Check the latest studies of Micronase.



On Jul, 25, 2026

18 people who take Celexa and Micronase together, and have interactions are studied.

Celexa and Micronase drug interactions.

What are the common drug interactions of Celexa and Micronase, by gender? *:

female:

  1. Dyspnoea exertional (breathlessness or shortness of breath)
  2. Haematemesis (vomiting of blood)
  3. Haemoglobin decreased
  4. Hypertension (high blood pressure)
  5. Overweight
  6. Pain in extremity
  7. Pancreatic carcinoma (pancreatic cancer)
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  9. Tardive dyskinesia (a disorder that involves involuntary movements)
  10. Type 2 diabetes mellitus

male:

  1. Atrioventricular block first degree (heart block first degree)
  2. Cardiac failure congestive
  3. Gynaecomastia (enlargement of the gland tissue of the male breast)
  4. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  5. Hypertension (high blood pressure)
  6. Hypoglycaemia (deficiency of glucose in the bloodstream)
  7. Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
  8. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  9. Lethargy (tiredness)
  10. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)

What are the common drug interactions of Celexa and Micronase, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Tardive dyskinesia (a disorder that involves involuntary movements)
  3. Type 2 diabetes mellitus

30-39:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

40-49:

  1. Lactic acidosis (low ph in body tissues)

50-59:

  1. Atrioventricular block first degree (heart block first degree)
  2. Cardiac failure congestive
  3. Cataract (clouding of the lens inside the eye)
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Cutaneous sarcoidosis (a multisystem disease with skin lesion)
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Dysarthria (speech disorder)
  8. Electrocardiogram t wave inversion
  9. Erectile dysfunction
  10. Gynaecomastia (enlargement of the gland tissue of the male breast)

60+:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Dyspepsia (indigestion)
  3. Dyspnoea exertional (breathlessness or shortness of breath)
  4. Haematemesis (vomiting of blood)
  5. Haemoglobin decreased
  6. Hypertension (high blood pressure)
  7. Overweight
  8. Pain in extremity
  9. Pancreatic carcinoma (pancreatic cancer)
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 27.78%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 16.67%
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 16.67%
  4. Pain: 1 person, 5.56%
  5. Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 1 person, 5.56%
  6. High Blood Cholesterol: 1 person, 5.56%
  7. Bipolar Disorder (mood disorder): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Celexa and Micronase?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Celexa and Micronase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Celexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Micronase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Celexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micronase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide and glyburide (the active ingredients of Celexa and Micronase, respectively), and Celexa and Micronase (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: